You’ll have to do your own research mate but it’s all there in BOT’s reports and announcements. Directors have put in hundreds of thousands of dollars to purchase direct shares, in addition to covering free options converting to shares. For sure they get given a fair few performance rights, but they certainly haven’t been shy putting their hands into their own pockets. DYOR!
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-979
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.015(3.80%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.5¢ | $3.489M | 9.104M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 893523 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 159482 | 2 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |